Characterising Immune Response to COVID-19

RIW submitted, won and managed an Innovate UK grant application to enable a collaborative research study with the Defence Science and Technology Laboratory (Dstl) and Hywel Dda University Health Board, with support from Accelerate at Swansea University.

RIW co-designed and managed the study, having taken it through the expedited COVID-19 research permissions and ethics processes. The blood sample analysis by Dstl is reaching its final stages and the findings are hoped to be published in late 2021.

Original Ethics approval: Characterising the immune response in COVID-19 [COVID-19] – Health Research Authority (

Publication(s): One or more likely in late 2021/early 2022